The use of AI in drug discovery has healthcare companies excited, as Milford Investment Analyst Dr Deborah Lambie discovered on her recent visit to the United States. She shared her findings with Heather du Plessis-Allan, including the cost and time-saving benefits of using AI in developing new drugs.
2024 © Milford Asset Management Limited Privacy Policy Terms & Conditions Disclosure Statement
Replacement Product Disclosure Statements are available here or on the relevant scheme’s offer register entry at the NZ Companies Office
Milford Funds Limited is the Manager and Issuer of the Milford KiwiSaver Plan and the Milford Investment Funds